Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 3”

199 trials

Showing 20 of 199 results

Early research (Phase 1)Study completedNCT02772627
What this trial is testing

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 22
Large-scale testing (Phase 3)Active Not RecruitingNCT03553836
What this trial is testing

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 976
Large-scale testing (Phase 3)Study completedNCT01866319
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 834
Large-scale testing (Phase 3)Study completedNCT03142334
What this trial is testing

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 994
Large-scale testing (Phase 3)Study completedNCT02337764
What this trial is testing

A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

Who this might be right for
Parkinson's Disease
Takeda 222
Large-scale testing (Phase 3)Study completedNCT03834506
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,030
Large-scale testing (Phase 3)Study completedNCT03066778
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Who this might be right for
Small Cell Lung Cancer (SCLC)
Merck Sharp & Dohme LLC 453
Post-approval studies (Phase 4)UnknownNCT00696215
What this trial is testing

The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Istanbul University 40
Large-scale testing (Phase 3)Study completedNCT04223193
What this trial is testing

Flexible-Dose Trial in Early Parkinson's Disease (PD)

Who this might be right for
Parkinson Disease
AbbVie 304
Large-scale testing (Phase 3)Study completedNCT02337725
What this trial is testing

TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Takeda 244
Not applicableLooking for participantsNCT05934747
What this trial is testing

Aim 3 Particle Swarm Optimization PIGD

Who this might be right for
Parkinson's Disease and Parkinsonism
University of Minnesota 30
Large-scale testing (Phase 3)Study completedNCT02642393
What this trial is testing

Study of Urate Elevation in Parkinson's Disease, Phase 3

Who this might be right for
Parkinson's Disease
Michael Alan Schwarzschild 298
Large-scale testing (Phase 3)Active Not RecruitingNCT04624204
What this trial is testing

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 672
Testing effectiveness (Phase 2)Study completedNCT04858074
What this trial is testing

Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Ibadan 19
Large-scale testing (Phase 3)Study completedNCT01155466
What this trial is testing

A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)

Who this might be right for
Parkinson Disease
Merck Sharp & Dohme LLC 778
Large-scale testing (Phase 3)Study completedNCT04934722
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Merck Sharp & Dohme LLC 186
Large-scale testing (Phase 3)Ended earlyNCT00211224
What this trial is testing

Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)

Who this might be right for
Multiple System AtrophyProgressive Supranuclear Palsy
King's College London 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT04995523
What this trial is testing

AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 212
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Large-scale testing (Phase 3)Study completedNCT05298423
What this trial is testing

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 610
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation